DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Wang X, Tirucherai G, Marbury TC. , et al.
Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.
J Clin Pharmacol 2016;
56 (05) 628-636
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.